logo

For the Inventor, By the Inventor

Longboat Key, FL, United States of America

Francis E O'Donnell, Jr

This inventor holds 10 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Hedgepath Pharmaceuticals, Inc., Accentia Biopharmaceuticals, Inc., Johns Hopkins University. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis E O'Donnell, Jr. Retrieved from https://idiyas.com/inventor/francis-e-o-donnell-jr-ydfcswza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 70.0

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Town and Country, MO (US) (2014)
  • Longboat Key, FL (US) (2012 - 2019)

Company Filing History:

goldMedal5 out of 5 
 
Hedgepath Pharmaceuticals, Inc.
 patents
silverMedal4 out of 4 
 
Accentia Biopharmaceuticals, Inc.
 patents
bronzeMedal2 out of 3,806 
 
Johns Hopkins University
 patents
4. 1 out of 1 
 
Accentia Biopharmceuticals, Inc.
 patent
where one patent can have more than one assignee

Years Active: 2012-2019

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 10363252 - Treatment of prostate cancer using hedgehog pathway inhibitors (2019-07-30),
2. 10328072 - Treatment of lung cancer using hedgehog pathway inhibitors (2019-06-25),
3. 9968600 - Treatment and prognostic monitoring of non-cancerous proliferation disorders using hedgehog pathway inhibitors (2018-05-15),
4. 9962381 - Treatment and prognostic monitoring of cancerous proliferation disorders using Hedgehog pathway inhibitors (2018-05-08),
5. 9279803 - Method of identifying patients not suitable for high-dose cyclophosphamide treatment (2016-03-08),
6. 9192609 - Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors (2015-11-24),
7. 9026372 - Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen (2015-05-05),
8. 8940319 - Formulations, devices and methods for treating and preventing mucositis (2015-01-27),
9. 8673321 - Cyclophosphamide in combination with anti-idiotypic vaccines (2014-03-18),
10. 8211460 - Formulations, devices and methods for treating and preventing mucositis (2012-07-03),

Title: The Inventor Profile of Francis E O'Donnell, Jr

Introduction:

Francis E O'Donnell, Jr is a distinguished inventor known for his groundbreaking contributions in the field of technology and innovation. With a keen eye for detail and a passion for problem-solving, he has made significant strides in the world of patents and inventions.

Latest Patents:

Francis E O'Donnell, Jr holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems. His latest patents focus on cutting-edge advancements in robotics and artificial intelligence, solidifying his reputation as a forward-thinker in the industry.

Career Highlights:

Throughout his illustrious career, Francis E O'Donnell, Jr has worked with leading tech companies and research institutions, spearheading projects that have pushed the boundaries of what is possible. His innovative spirit and dedication to excellence have earned him recognition as a trailblazer in the field of technology.

Collaborations:

Francis E O'Donnell, Jr has collaborated with top-tier engineers, scientists, and inventors from around the globe, fostering a culture of creativity and innovation. His ability to work seamlessly in multidisciplinary teams has led to the development of groundbreaking technologies that have the potential to shape the future.

Conclusion:

In conclusion, Francis E O'Donnell, Jr stands as a visionary inventor whose passion for innovation knows no bounds. His relentless pursuit of excellence and commitment to pushing the envelope have cemented his

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…